La pharmacovigilance et l'évaluation du risque médicamenteux : intérêt, fonctionnement et méthodes
Authors:
- Jean-Louis MontastrucJMJean-Louis Montastruc
- Agnès SommetASAgnès Sommet
- Isabelle LacroixILIsabelle Lacroix
- Pascale OlivierPOPascale Olivier
- Geneviève DurrieuGDGeneviève Durrieu
- Christine Damase-MichelCDChristine Damase-Michel
- Maryse Lapeyre-MestreMLMaryse Lapeyre-Mestre
- Haleh BagheriHBHaleh Bagheri
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Revue du Rhumatisme
- Vol. 73 (10-11) , 1021-1024
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Using a capture–recapture method to assess the frequency of adverse drug reactions in a French university hospitalBritish Journal of Clinical Pharmacology, 2006
- Under-Reporting of Adverse Drug ReactionsDrug Safety, 2006
- Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance DatabaseEuropean Journal of Clinical Pharmacology, 2004
- Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signalsEuropean Journal of Clinical Pharmacology, 2004
- Mechanism of action of adverse drug reactions: an overviewPharmacoepidemiology and Drug Safety, 1997